• Home
  • MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

Author List
Hirata H, Hinoda Y, Ueno K, Nakajima K, Ishii N, Dahiya R
Publication
Carcinogenesis
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1158155
Publication Year
2011
PubMed ID
22180573
Publication Title
Hirata H, Hinoda Y, Ueno K, Nakajima K, Ishii N, Dahiya R. MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. Carcinogenesis. 2012 Mar; 33(3):501-8.